4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001628280-22-018113
Director returned 60,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2022-06-23 | Returned to the company | −13,250 | $31.10 | $412,076 | 2,017,106 | D |
| Tessier-Lavigne Marc Director | 2022-06-24 | Returned to the company | −39,984 | $30.53 | $1,220,708 | 1,977,122 | D |
| Tessier-Lavigne Marc Director | 2022-06-24 | Returned to the company | −6,766 | $31.08 | $210,261 | 1,970,356 | D |
Loading xslF345X03/wf-form4_165637764875845.xml…